期刊文献+

亚甲基蓝法在乳腺癌前哨淋巴结活检术60例的临床应用 被引量:6

An analysis on sentinel lymph node biopsy marked with methylene-blue in 60 cases of breast cancer
暂未订购
导出
摘要 目的探讨乳晕下注射亚甲基蓝示踪法进行前哨淋巴结活检术(SLNB)在乳腺癌治疗中的临床意义。方法以60例可手术乳腺癌患者作为研究对象,临床体检腋窝淋巴结(ALN)阴性,均单独采用亚甲基蓝作为前哨淋巴结(SLN)示踪剂。结果全部行乳腺癌改良根治术,行SLN和ALN活检,灵敏度为95.65%,准确率为91.07%,假阴性率为13.04%,假阳性率8.70%。SLNB与ALN转移检测比较效果相一致,准确率高。结论前哨淋巴结活检术准确率较高,能较准确地预测和判定乳腺癌腋窝淋巴结的转移情况。 Objective To evaluate the efficacy of sentinel lymph node biopsy(SLNB) by using subareolar injection ofmethylene blue in the management of breast cancer.Methods Sixty cases of breast tumor without axillary lymph node(ALN) by palpation were enrolled in this study.Results All patients were treated by segment resection plus axillary lymph node dissection.Biopsies of sentinel lymph nodes and axillary lymph nodes were taken in all patients.The sensitivity of SLNB was 95.65%,its accurate rate was 91.07%,its false negative rate was 13.04%,and its false positive rate was 8.70%.There was no significant difference between the effect of detection of metastasis by sentinel lymph node or axillary lymph node biopsy.Conclusion Due to the high accuracy of sentinel lymph node biopsy in our team,the axillary lymph node metastasis of breast cancer can be predicted and judged.
出处 《安徽医学》 2012年第4期437-439,共3页 Anhui Medical Journal
关键词 乳腺癌 活组织检查 前哨淋巴结 亚甲基蓝染色法 Breast cancer Lymph node biopsy Sentinel lymph node Methylene-blue
  • 相关文献

参考文献4

二级参考文献44

  • 1许羽,陈森东,何瑞婵,黄桂睿.前哨淋巴结的分布与乳腺癌肿块的相关性[J].中国误诊学杂志,2006,6(6):1056-1057. 被引量:5
  • 2李玉阳,洪凡真,王永胜,仲伟霞,左文述.Mammotome在早期乳腺癌原发肿瘤诊断中的应用[J].中华肿瘤防治杂志,2007,14(9):706-708. 被引量:24
  • 3Simmons RM. Review of sentinel lymph node credentialing: how many cases are enough? [J]. J Am Coll Surg, 2001; 193(2):206.
  • 4Van Diest PJ, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer [J]. Histopathology, 1999; 35(1):14.
  • 5Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery [J]. Br J Surg, 2000; 87(5):597.
  • 6Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer [J]. Am J Surg, 2001; 182(6):609.
  • 7Chilosi M, Lestani M, Pedron S, et al. A rapid immunostaining method for frozen sections [J]. Biotech Histochem, 1994; 69(4):235.
  • 8Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation [J]. N Engl J Med, 1985; 312(11):674.
  • 9Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award [J]. Arch Surg, 1987; 122(11):1244.
  • 10Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer [J]. N Engl J Med, 1997; 337(14):956.

共引文献57

同被引文献55

  • 1仇爱峰,徐青,王庆庆.新辅助化疗对乳腺癌患者腋窝前哨淋巴结活检的影响[J].山东医药,2005,45(36):34-35. 被引量:8
  • 2王永胜.乳腺癌前哨淋巴结活检的安全性[J].中国癌症杂志,2006,16(9):685-688. 被引量:28
  • 3Goldhirsch A, Ingle JN, Gelber RD, et al.Thresholds for therapies:highlights of the gallen international expert consensus on the primary therapy of early breast cancer[J].Ann Oncol,2009,20 ( 8 ) : 1319-1329.
  • 4Krag DN, Anderson SJ, Julian TB, et al.Sentiinel-lymph-node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer:overall survival findings from the NSABP B-32 randomised phase 3 trial[J].Lancet Oncol,2010, 11 ( 1 ) 927-933.
  • 5Krag DN,Anderson SJ,Julian TB,et al.Sentiinel-lymplh-node resection Compared with conventional axillary lymph node dissection in clinically node-negative patients with berast cancer:overall survival findings from theNSABPB-32randomisedphase3trial [J].Lancet oncol,2010,11 (1):927- 933.
  • 6GoldhirschA,IngleJN,GelberRD,etal.Thresholdsfortherapies:highlightsoftheStGallenInternationalExpertConsensusontheprimarytherapyofearlybreastcancer2009[J].AnnOncol,2009,20(8):1319-1329.
  • 7WarmuthMA,BowenG,ProsnitzLR,etal.Complicationsofaxillarylymphnodedissectionforcarcinomaofthebreast:areportbasedonapatientsurvey[J].Cancer,1998,83(7):1362-1368.
  • 8SaizE,ToonkelR,PoppitiRJ,etal.Infiltratingbreastcarcinomasmallerthan0.5centimeters:islymphnodedissectionnecessary[J].Cancer,1999,86(10):2186-2188.
  • 9AshikagaT,KragDN,LandSR,etal.MorbidityresultsfromtheNSABPB32trialcomparingsentinellymphnodedissectionversusaxillarydissection[J].JSurgOncol,2010,102(2):111-118.
  • 10VeronesiU,PaganelliG,VialeG,etal.Arandomizedcomparisonofsentinelnodebiopsywithroutineaxillarydissectioninbreastcance[J].NEnglJMed,2003,349(6):546-553.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部